The treatment combines a new drug, inavolisib, with two older breast cancer drugs, fulvestrant (Faslodex ®) and palbociclib (Ibrance ®) . Inavolisib, which targets PIK3CA mutations, appears to be a ...
Treatment for breast cancer starts with a correct diagnosis. We’re here to help you take the first steps toward getting the best cancer care. You may be reading this because you’re thinking about ...